Related Experiment Video
Updated: Aug 10, 2026

Depletion of Specific Cell Populations by Complement Depletion
Published on: February 5, 2010
Therapeutic Inhibition of Complement: Well Worth the Risk
1Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Abstract:
Complement is an integral part of the immune system and protects against infection. Complement-mediated immunopathology in many autoimmune diseases and syndromes has led to the therapeutic targeting of complement and to questions around the safety of complement inhibition. Here; I examine and clarify the risks associated with complement therapeutics.
Related Concept Videos
Therapeutic Index
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Complement System
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

